Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes [0.03%]
自动胰岛素输送系统能够安全改善1型糖尿病老年患者血糖控制效果
Carmen Quirós,Montserrat Granados,María J Picón et al.
Carmen Quirós et al.
Objective: To evaluate real-world glycemic outcomes, safety, treatment satisfaction, cognition, and frailty in older adults with type 1 diabetes (T1D) using advanced hybrid closed-loop (aHCL), and to compare them with tho...
Ensuring Equitable Access to Diabetes Technology for People with Disabilities [0.03%]
确保残疾人公平获得糖尿病技术
Rohan Maini,Rozalina G McCoy,Grenye O&#x;Malley et al.
Rohan Maini et al.
Perioperative Blood Glucose Control following Implementation of Standardized Protocols in Children and Adolescents with Diabetes Undergoing Surgery [0.03%]
实施标准化方案后糖尿病儿童和青少年手术围术期血糖控制水平发生变化
Abdulrahman Habib,Nour Almoutairi,Evangelia Elenakis et al.
Abdulrahman Habib et al.
Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study [0.03%]
TIMELY观察性队列研究中的妊娠期2型糖尿病妇女的连续血糖监测指标
Denice S Feig,Jennifer M Yamamoto,Afshan Zahedi et al.
Denice S Feig et al.
Background: Continuous glucose monitoring (CGM) is increasingly used in pregnancy, but data on its use in women with type 2 diabetes are limited. Aims: ...
Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World Study [0.03%]
儿童和青少年1型糖尿病患者胰岛素自动给药治疗的三年疗效研究：一项多中心真实世界研究
Bruno Bombaci,Fortunato Lombardo,Marta Bassi et al.
Bruno Bombaci et al.
Introduction: Evidence on the long-term durability of glycemic control beyond the first year of automated insulin delivery therapy remains limited, particularly in large multicenter pediatric cohorts. The present study ai...
Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes [0.03%]
评估客观测量1型糖尿病青年餐时胰岛素注射频率的效果
Jessica S Pierce,Mark A Clements,Brent Lockee et al.
Jessica S Pierce et al.
Objective measures of self-management are critical for understanding glycemic outcomes in individuals with type 1 diabetes (T1D). The mealtime insulin bolus score (BOLUS), derived from insulin pump data, is a validated indicator of mealtime...
A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems [0.03%]
一种简单的餐前 bolus 策略可有效改善青少年和年轻成人使用多个自动化胰岛素输注系统的效果
Alexandra Sawyer,Lindsey Towers,Samantha Lange et al.
Alexandra Sawyer et al.
Background: Carbohydrate counting (CC) is challenging and may be a barrier to automated insulin delivery (AID) use. Given the ability of AID to modulate insulin delivery, a simpler meal bolus strategy may be adequate for ...
Use of Low-Glucose Alerts and Their Impact on Continuous Glucose Monitoring Outcomes in Real-World Use of the MiniMed 780G System [0.03%]
低血糖报警在MiniMed 780G系统真实世界使用中的应用及其对持续葡萄糖监测结果的影响
Javier Castañeda,Margaret Liu,Joanna Juachon et al.
Javier Castañeda et al.
Objective: Hypoglycemia remains a major concern in insulin therapy and has limited intensive glycemic control. Although automated insulin delivery substantially reduces hypoglycemia risk, relatively high low-glucose alert...
Incident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes [0.03%]
1型糖尿病成人接受 tirzepatide 辅助治疗1年后发生糖尿病视网膜病变的病例报告
Sarit Polsky,Elizabeth Beck,Archi Shah et al.
Sarit Polsky et al.
Introduction: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like polypeptide-1 receptor agonist, has significantly increased in use in overweight (OW)/obese people with type 1 diabetes (T1D...
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2F [0.03%]
法国全国性观察研究OB2F：自动化胰岛素输注系统真实世界环境下为期2年的随访结果
Jean-Baptiste Julla,Chloé Amouyal,Sandrine Lablanche et al.
Jean-Baptiste Julla et al.
Background: Automated insulin delivery (AID) systems improve glycemic control in people with type 1 diabetes (PwT1D), but evidence on effectiveness and safety in routine clinical practice over 2 years remains limited. ...